Steroid-Refractory Autoimmune Myocarditis after Pembrolizumab Therapy: Failure of Equine Anti-Thymocyte Globulin to Prevent Heart Failure

While immune checkpoint inhibitors (ICIs) are improving outcomes for many cancers, they can have severe adverse effects. Though cardiac immune-related adverse effects (irAEs) are rare, they have considerable morbidity and mortality. Prior case studies have demonstrated successful treatment of ICI in...

Descripción completa

Detalles Bibliográficos
Autores principales: Baclig, NV, Ngo, C, Yeh, AC, Chung, SH, Cheng, A, Grim, J, Graf, SA, Yang, KC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881190/
https://www.ncbi.nlm.nih.gov/pubmed/36712142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881190/
https://www.ncbi.nlm.nih.gov/pubmed/36712142

Ejemplares similares